Canada NewsWire
QUEBEC CITY, Jan. 24, 2019
QUEBEC CITY, Jan. 24, 2019 /CNW Telbec/ - Opsens Inc.
("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today held its annual general shareholders'
meeting (the "Meeting") in Quebec City, Canada.
At the Meeting, all the individuals nominated as directors were duly elected to the Board by a majority of votes cast by the
shareholders present in person or by proxy. The shareholders re-elected Denis M. Sirois, Gaétan
Duplain, Denis Harrington, Jean Lavigueur, Pat Mackin and Louis Laflamme to the Board.
|
Name
|
For
%
|
For
Votes
|
Withheld
%
|
Withheld
Votes
|
|
Denis M. Sirois
|
98.82
|
55,185,535
|
1.18
|
661,425
|
|
Gaétan Duplain
|
98.74
|
55,143,060
|
1.26
|
703,900
|
|
Denis Harrington
|
91.97
|
51,359,861
|
8.03
|
4,487,099
|
|
Jean Lavigueur
|
98.82
|
55,187,160
|
1.18
|
659,800
|
|
Pat Mackin
|
98.77
|
55,161,160
|
1.23
|
685,800
|
|
Louis Laflamme
|
99.89
|
55,785,860
|
0.11
|
61,100
|
The shareholders present or represented by proxy at the meeting also voted at a rate of 85% in favor of the appointment of
Deloitte LLP, as independent auditors of Opsens for the coming year and have authorized directors to determine their
remuneration.
|
Independent
Auditors
|
For
%
|
For
Votes
|
Withheld
%
|
Withheld
Votes
|
|
Deloitte
|
100
|
58,223,155
|
0
|
250
|
The report of the voting results is also available on SEDAR at www.sedar.com.
About Opsens Inc. (www.opsens.com or www.opsensmedical.com)
Opsens focuses mainly on the measure of FFR and dPR in interventional cardiology. Opsens offers an advanced optical-based
pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product,
the OptoWire, is a 2nd-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and
excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 50,000 patients in more than 30
countries. It is approved for sale in the United States, European Union, Japan, and Canada.
Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors
that may cause actual results, performance and achievements of Opsens to be materially different from any future results,
performance or achievements expressed or implied by the said forward-looking statements.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
SOURCE OPSENS Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/24/c0426.html